glp 1 clinical studies The transformative breakthroughs in GLP-1 research recognized by the 2024 Lasker~DeBakey award | Current Medicine Can one drug do it

This article explores current clinical evidence, provider decision-making frameworks, and how genetic insights may inform a personalized conversation with your healthcare

Internal research shows 50% of GLP-1 users already belong to a gym, and those who dont are twice as likely as the general population to express interest in joining.

GLP-1 semaglutide shows improved liver scarring in advanced MASH, early cirrhosis, offering a potential new treatment option in a large global trial study.

Methods A comprehensive literature search was conducted to synthesize the current preclinical and clinical evidence

GLP-1 weight loss drugs are changing how people eat and what they are willing to pay for food, with protein emerging as a premium category, according to new analysis from Arizona State University | Alternative Proteins | Food Tech | Food Production | Plant-Based Food | Cultivated Meat

Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction.